Contribution of direct and indirect recognition pathways to T cell alloreactivity.
Open Access
- 1 June 1993
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 177 (6) , 1643-1650
- https://doi.org/10.1084/jem.177.6.1643
Abstract
T cells from an HLA-DR11/DR12 responder were stimulated in mixed lymphocyte culture with cells carrying the DR1 antigen. After priming, T cells proliferated in response to both DR1-positive-stimulating cells and a peptide derived from a polymorphic region of the HLA-DR beta 1*0101 chain presented by responder's antigen-presenting cells (APC). The dominant epitope recognized by the primed T cells corresponded to residue 21-42 and was presented by the responder's HLA-DR12 antigen. The DR1 peptide-reactive T cells express T cell receptor V beta 3. The results demonstrate that allopeptides derived from the processing and presentation of donor major histocompatibility complex molecules by host-derived APC trigger alloreactivity. The frequency of T cells engaged in the indirect pathway of allorecognition is about 100-fold lower than that of T cells participating in the direct recognition of native HLA-DR antigen. However, indirect allorecognition may play an important role in chronic allograft rejection, a phenomenon that is mediated by the activation of T helper cells and of alloantibody-producing B cells.Keywords
This publication has 20 references indexed in Scilit:
- Processed MHC class I alloantigen as the stimulus for CD4+ T-cell dependent antibody-mediated graft rejectionImmunology Today, 1992
- T cell recognition of self-human histocompatibility leukocyte antigens (HLA)-DR peptides in context of syngeneic HLA-DR molecules.The Journal of Experimental Medicine, 1992
- Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection.The Journal of Experimental Medicine, 1992
- Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo.The Journal of Experimental Medicine, 1991
- Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule.The Journal of Experimental Medicine, 1990
- The molecular basis of alloreactivityImmunology Today, 1990
- A novel MHC class II epitope expressed in thymic medulla but not cortexNature, 1989
- T cells sensitized to synthetic HLA-DR3 peptide give evidence of continuous presentation of denatured HLA-DR3 molecules by HLA-DP.The Journal of Experimental Medicine, 1989
- Effector cells in allelic H-2 class I-incompatible skin graft rejection.The Journal of Experimental Medicine, 1987
- Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences.The Journal of Experimental Medicine, 1986